Concord Biotech Ltd experienced a notable 8.53% surge, reaching an intraday high of Rs 1147.2, amidst a bearish broader market where the Sensex declined by 0.11%. This rally marks an uptick in investor sentiment for the stock, which had previously been underperforming over the past year. While the stock currently trades above its short-term moving averages, it remains below longer-term ones, indicating a potential recovery phase rather than a definitive breakout. Mixed technical indicators suggest a rebound could be temporary, raising questions about the sustainability of today’s gains amid the overall market’s weakness.
Disclaimer: This summary is written by AI, which can make mistakes. Please follow up on any news information from additional sources.
Link to original article source: https://www.marketsmojo.com/news/stocks-in-action/concord-biotech-ltd-hits-intraday-high-with-853-surge-on-2-june-2026-4030844
